The significance of solute carrier group of genes in the pathogenesis and treatment of diabetic microvascular complications

Singh K., Yuzvenko T. The significance of solute carrier group of genes in the pathogenesis and treatment of diabetic microvascular complications. Journal of Education, Health and Sport. 2020;10(1):253-258. eISSN 2391-8306. DOI http://dx.doi.org/10.12775/JEHS.2020.10.01.028

https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/JEHS.2020.10.01.028

http://dx.doi.org/10.5281/zenodo.3873184       

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

© The Authors 2020;

This article is published with open access at Licensee Open Journal Systems of Nicolaus Copernicus University in Torun, Poland

Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license Share alike.

(http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.

 The authors declare that there is no conflict of interests regarding the publication of this paper.

 Received: 20.12.2019. Revised: 25.12.2019. Accepted: 31.01.2020.

The significance of solute carrier group of genes in the pathogenesis and treatment of diabetic microvascular complications

K. Singh, T. Yuzvenko

Ukrainian centre for endocrine surgery and organ transplantation of endocrine organs and tissues, MOH of Ukraine, Kyiv

Singh K. - https://orcid.org/0000-0002-1562-7207

Yuzvenko T. - https://orcid.org/0000-0003-4229-2075

Abstract

Aim- To study the impact of the solute carrier group of genes on the mechanisms involved in hyperglycemia induced tissue damage and its implication on the treatment of diabetic microvascular complications.

Introduction – the estimated figure of people suffering from diabetes worldwide in 2019 was 9.3% (463 million people) and the projected estimates for 2030 is an alarming figure of approximately 578 million people [1]. Various pathological processes are responsible for the development of diabetes, the irreversible factor is the destruction of β-cells in the pancreas leading to insulin insufficiency, or other factors such as obesity and abnormal carbohydrate and fat metabolism which leads to insulin resistance and diminished tissue response to insulin. Defects in insulin secretion and insulin action frequently coexist in diabetics [2].

The damaging effects of hyperglycemia are classified into microvascular complications - diabetic retinopathy, neuropathy and nephropathy, and macrovascular complications - coronary artery disease, peripheral artery disease and stroke [3]. The effects of hyperglycemia are not seen in all cells of the body, but are distinct only in certain types of cells: neurons and Schwann cells in peripheral nerves, capillary endothelial cells, mesengeal cells in the renal glomerulus due to their inability to effectively maintain a constant level of glucose, in contrast most cells are able to reduce the transport of glucose when exposed to hyperglycemia [4, 5, 6].

Key words: solute carrier family; transketolase; PPP; thiamine transporter; diabetic peripheral neuropathy.